Segregating Stock for FDA Approved Medical Devices

Maintaining high quality standards in medical device manufacturing requires strict control over nonconforming products. Any lapse in identifying or handling suspect items can introduce serious compliance and safety risks.

With the shift to QMSR, regulators now expect identification, segregation, and disposition processes to be both robust and verifiable. Controls must be actively enforced and clearly demonstrated on the shop floor, not just documented in procedures.

LocaXion explains why traditional methods like paper tags often fail when managing FDA approved medical devices. Manual tagging can be overlooked or misplaced, making it difficult to ensure continuous control in fast-moving production environments.

By using Digital Twins, manufacturers can maintain a continuous state of control and automate the physical segregation of suspect stock. This approach helps prevent quality escapes, reduces the risk of major audit findings, and strengthens overall compliance.